Skip to main content
. Author manuscript; available in PMC: 2022 Jan 19.
Published in final edited form as: J Mol Cell Cardiol. 2021 Sep 3;162:32–42. doi: 10.1016/j.yjmcc.2021.08.013

Fig. 4.

Fig. 4.

Phosphofructokinase has little effect on hexosamine biosynthetic pathway activity in the heart. (A) Schematic of hexosamine biosynthetic pathway. (B) Pool totals and (C) isotopologue abundances of hexosamine biosynthetic pathway intermediates in hearts of GlycoLo, GlycoHi, and WT hearts. *p < 0.05, **p < 0.01, ****p < 0.0001, (panel B) one-way ANOVA or (panel C) two-way ANOVA with Tukey’s multiple comparison test, n = 4–5 hearts per group.